Minifenestration type I thyroplasty using an expanded polytetrafluoroethylene implant

Area of Science:

• Otolaryngology
• Vocal fold surgery
• Biomaterials in medicine

Background:

• Laryngeal incompetence presents a significant challenge in voice restoration.
• Current treatment options for laryngeal incompetence lack an ideal, universally effective technique.
• Minimally invasive surgical approaches are sought to improve outcomes and reduce morbidity.

Purpose of the Study:

• To evaluate the clinical efficacy and safety of minifenestration type I thyroplasty using a novel expanded polytetrafluoroethylene (ePTFE) device.
• To assess the feasibility of vocal fold medialization with a new ePTFE implant.
• To report outcomes of this technique in a series of patients.

Main Methods:

• A retrospective clinical experience involving 26 patients undergoing minifenestration type I thyroplasty.
• Insertion of a thin ribbon of ePTFE through a 4-mm fenestration for vocal fold medialization.
• Evaluation of outcomes based on clinical assessment of voice quality and function.

Main Results:

• The ePTFE device was successfully implanted in 26 patients over a 3-year period.
• Good or satisfactory results were achieved in 96% of the cases.
• The technique demonstrated advantages including ease of insertion, low cost, biocompatibility, and avoidance of arytenoid adduction.

Conclusions:

• Minifenestration type I thyroplasty with the new ePTFE device is a highly effective treatment for laryngeal incompetence.
• This technique offers a safe, cost-effective, and minimally invasive solution for vocal fold medialization.
• The ePTFE implant provides a reliable option for restoring voice function with high patient satisfaction.